Genmab A/S (CPH:GMAB)
Denmark · Delayed Price · Currency is DKK 1,992.00
-7.00 (-0.35%)
Aug 10, 2026, 4:59 PM CET
Genmab Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Jan '24 Jan 1, 2024 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 788 | 963 | 1,133 | 631 | 783.33 | 452.29 |
Depreciation & Amortization | 60 | 57 | 52 | 43 | 52.01 | 29.67 |
Other Amortization | 77 | 14 | 8 | - | - | - |
Asset Writedown & Restructuring Costs | 32 | 32 | 17 | - | - | - |
Loss (Gain) From Sale of Investments | -7 | -65 | -136 | 21 | 94.54 | 105.39 |
Stock-Based Compensation | 156 | 128 | 105 | 85 | 63.07 | 47.42 |
Other Operating Activities | -90 | -168 | 56 | 93 | -166.52 | -186.15 |
Change in Accounts Receivable | -190 | -166 | -230 | 116 | -305.03 | -154.33 |
Change in Inventory | -5 | -9 | -1 | -8 | - | - |
Change in Accounts Payable | 80 | 400 | 122 | 90 | 40.66 | 46.5 |
Change in Unearned Revenue | -10 | - | - | - | - | - |
Operating Cash Flow | 891 | 1,186 | 1,126 | 1,071 | 562.07 | 340.79 |
Operating Cash Flow Growth | -14.08% | 5.33% | 5.13% | 90.55% | 64.93% | -67.77% |
Capital Expenditures | -22 | -37 | -27 | -53 | -45.55 | -38.55 |
Cash Acquisitions | -7,215 | -7,215 | -1,783 | - | - | - |
Sale (Purchase) of Intangibles | -1 | -18 | -17 | -1 | - | - |
Investment in Securities | 1,605 | 1,627 | 380 | -131 | -351.15 | -108.45 |
Investing Cash Flow | -5,633 | -5,643 | -1,447 | -185 | -396.7 | -146.99 |
Long-Term Debt Issued | - | 5,500 | - | - | - | - |
Long-Term Debt Repaid | - | -13 | -9 | -14 | -10.49 | -8.87 |
Net Debt Issued (Repaid) | 5,359 | 5,487 | -9 | -14 | -10.49 | -8.87 |
Issuance of Common Stock | 19 | 23 | 19 | 21 | 40.23 | 20.65 |
Repurchase of Common Stock | -147 | -448 | -576 | -96 | -143.1 | -76.02 |
Other Financing Activities | -275 | -273 | - | - | - | - |
Financing Cash Flow | 4,956 | 4,789 | -566 | -89 | -113.36 | -64.24 |
Foreign Exchange Rate Adjustments | -7 | 3 | 63 | -12 | 82.47 | 130.01 |
Net Cash Flow | 207 | 335 | -824 | 785 | 134.48 | 259.57 |
Free Cash Flow | 869 | 1,149 | 1,099 | 1,018 | 516.52 | 302.24 |
Free Cash Flow Growth | -12.75% | 4.55% | 7.96% | 97.09% | 70.90% | -69.98% |
Free Cash Flow Margin | 21.04% | 30.89% | 35.21% | 42.59% | 24.79% | 23.48% |
Free Cash Flow Per Share | 13.94 | 18.33 | 17.00 | 15.45 | 7.83 | 4.58 |
Levered Free Cash Flow | 870.63 | 1,068 | 915.13 | 777.92 | 305.1 | 259.8 |
Unlevered Free Cash Flow | 995.75 | 1,106 | 926.38 | 784.17 | 308.6 | 261.04 |
Cash Interest Paid | 201 | 10 | 5 | 3 | 2.3 | 1.84 |
Cash Income Tax Paid | 241 | 460 | 50 | 155 | 227.44 | 113.49 |
Change in Working Capital | -125 | 225 | -109 | 198 | -264.37 | -107.83 |